Seeing Is Believing
Currently, out of the existing stock ratings of Richard Newitter - 231 which are a Buy (64.35%), 128 which are a Hold (35.65%)
Analyst Richard Newitter works at TRUIST and is covering the Healthcare sector with 671 price targets and ratings displayed on 29 stocks. Previously, Richard Newitter worked at LEERINK.
Richard Newitter's average stock forecast success ratio is 58.8% with an average time for price targets to be met of 178.41 days.
Most recent stock forecast was given on TMCI, Treace Medical Concepts at 10-Nov-2023.
Analyst best performing recommendations are on SIEN (SIENTRA).
The best stock recommendation documented was for TFX (TELEFLEX) at 1/31/2023. The price target of $260 was fulfilled within 2 days with a profit of $18.01 (7.44%) receiving and performance score of 37.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
65
$-10.85 (-14.30%)
85
1 days ago
4/8 (50%)
$9.3 (13.18%)
157
Buy
88
$12.15 (16.02%)
95
15 days ago
6/9 (66.67%)
$15.25 (22.51%)
253
Buy
86
$10.15 (13.38%)
98
19 days ago
6/13 (46.15%)
$14.74 (20.11%)
208
Buy
95
$19.15 (25.25%)
88
2 months 27 days ago
2/4 (50%)
$9.57 (13.83%)
94
Buy
95
$19.15 (25.25%)
90
3 months 18 days ago
4/6 (66.67%)
$8.19 (11.88%)
261
Which stock is Richard Newitter is most bullish on?
Which stock is Richard Newitter is most reserved on?
What Year was the first public recommendation made by Richard Newitter?